How bioprinting pluripotent stem cells can take us closer to an Alzheimer’s cure Bioprinting
Alzheimer’s, Parkinson’s and other neurological disorders affect millions of people across the globe and are expected to become more prevalent as populations age. Despite how widespread the conditions are, however, there are still no real cures fo the diseases, only treatments to lessen or control symptoms. Fortunately, 3D bioprinting processes are presenting a potential avenue for a cure, and researchers are beginning to explore the technology for drug screening applications. Canadian biomedical engineer Stephanie Willerth is one such researcher who is pioneering the use of bioprinting for brain tissues with her research group.